Please assess the completion status of the following clinical trial:

Trial Title: Effects of Buspirone in Opiate Withdrawal

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* fulfilled DSM IV diagnostic criteria for opioid dependence~* used heroin daily for at least the prior 6 months with claimed heroin use of at least 2.5g/week~* physical dependence on opiates as determined by history and observation~* admission urine samples demonstrating heroin use~* expressed willingness to participate in a randomized, double-blind, placebo-controlled study for 14 days.~Exclusion Criteria:~* current or past Axis I psychiatric disorder other than opioid dependence~* evidence of significant neurological, gastrointestinal, hepatic, cardiovascular, renal, endocrine or hematologic disease~* seropositive status for the human immunodeficiency virus

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).